Related Experiment Video
Updated: Aug 13, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Differential requirement for Rho family GTPases in an oncogenic insulin-like growth factor-I receptor-induced cell
1Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029, USA.
Abstract:
Insulin-like growth factor I receptor (IGFR) plays an important role in cell growth and transformation. We dissected the downstream signaling pathways of an oncogenic variant of IGFR, Gag-IGFR, called NM1. Loss of function mutants of NM1, Phe-1136 and dS2, that retain kinase activity but are attenuated in their transforming ability were used to identify signaling pathways that are important for transformation of NIH 3T3 cells. MAPK, phospholipase C gamma, and Stat3 were activated to the same extent by NM1 and its two mutants, suggesting that activation of these pathways, individually or in combination, was not sufficient for NM1-induced cell transformation. The mutant dS2 has decreased IRS-1 phosphorylation levels and IRS-1-associated phosphatidylinositol 3'-kinase activity, suggesting that this impairment may be in part responsible for the defectiveness of dS2. We show that Rho family members, RhoA, Rac1, and Cdc42 are activated by NM1, and this activation, particularly RhoA and Cdc42, is attenuated in both mutants of NM1. Dominant negative mutants of Rho, Rac, and Cdc42 inhibited NM1-induced cell transformation, as measured by focus and colony forming ability. Dominant negative Rho most potently inhibited the focus forming activity, whereas Cdc42 was most effective in inhibiting the colony forming ability of NM1-expressing cells. Conversely, constitutively activated (ca) Rho is more effective than ca Rac or ca Cdc42 in rescuing the focus forming ability of the mutants. By contrast, ca Cdc42 is most effective in rescuing the colony forming ability of both mutants.
Insights
Oncogenic Insulin-like Growth Factor I Receptor (IGFR) signaling involves Rho family GTPases, particularly RhoA and Cdc42, which are crucial for cell transformation. These GTPases mediate key aspects of IGFR-driven cell growth and focus formation.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Insulin-like Growth Factor I Receptor (IGFR) is vital for cell growth and transformation.
- An oncogenic IGFR variant, Gag-IGFR (NM1), drives cellular transformation.
- Understanding NM1's downstream signaling is key to identifying cancer mechanisms.
Purpose of the Study:
- To identify signaling pathways critical for NM1-induced NIH 3T3 cell transformation.
- To investigate the role of Rho family GTPases in IGFR-mediated oncogenesis.
- To differentiate the functions of RhoA, Rac1, and Cdc42 in cellular transformation.
Main Methods:
- Utilized loss-of-function mutants (Phe-1136, dS2) of NM1 to probe signaling pathways.
- Assessed activation of MAPK, phospholipase C gamma, and Stat3 pathways.
- Examined Rho family GTPase (RhoA, Rac1, Cdc42) activation and function using dominant-negative and constitutively active mutants.
- Measured cell transformation via focus formation and colony-forming assays.
Main Results:
- MAPK, phospholipase C gamma, and Stat3 activation were not sufficient for transformation.
- Mutant dS2 showed reduced IRS-1 phosphorylation and phosphatidylinositol 3'-kinase activity.
- NM1 activated RhoA, Rac1, and Cdc42; activation was attenuated in mutants.
- Dominant-negative RhoA and Cdc42 inhibited transformation, with distinct effects on focus vs. colony formation.
- Constitutively active RhoA and Cdc42 differentially rescued transformation defects.
Conclusions:
- Rho family GTPases, especially RhoA and Cdc42, are essential mediators of NM1-induced cell transformation.
- Specific Rho GTPases play distinct roles in different aspects of transformation (e.g., focus vs. colony formation).
- Targeting Rho GTPase signaling may offer therapeutic strategies against IGFR-driven cancers.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway

